HymonBio has achieved another success with its core technology and innovative products, winning the “Certificate of Brand for Export Commodities” issued by the China Council for the Promotion of International Trade; it is also a recognition and encouragement for HymonBio’s innovative technology and foreign trade export.
The company focuses on development, production and sales of products related to the precision medicine industry; 11 products have obtained Chinese medical device certificates; 59 products have obtained EU CE certificates, 1 product has obtained FDA certificates, and the products are exported to Europe, America, Asia-Pacific and other regions.
Hymon® SARS-CoV-2 Test Kit has received US FDA EUA and cited by the FDA commissioner; it has also been certified and registered by many countries, including the EU CE; and sold around the world. The Colorectal Cancer Screening Kit uses ECS Magnetic Bead Extraction Technology and MoLock technology, and covers multiple gene markers, leading to ultra-high sensitivity and specificity; it is used for early screening and prognosis monitoring of tumors.
In the post-epidemic era, HymonBio adheres to innovation, actively integrates into the international market, and goes overseas.
Post time: Jun-06-2023